SCHEMBL25609121

SCHEMBL25609121

COc1ccc(CN(C(=O)OC(C)(C)C)C(CCO)CCO)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.41
▸ HTT P42858 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ L3MBTL1 Q9Y468 2/20 0.40
▸ NR1D1 P20393 1/20 0.40
▸ LDHA P00338 1/20 0.39
▸ TDP1 Q9NUW8 2/20 0.39
▸ ACHE P22303 1/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ PSEN1 P49768 1/20 0.38
▸ PSEN2 P49810 1/20 0.38
▸ APH1B Q8WW43 1/20 0.38
▸ NCSTN Q92542 1/20 0.38
▸ APH1A Q96BI3 1/20 0.38
▸ PSENEN Q9NZ42 1/20 0.38
▸ APLNR P35414 1/20 0.38
▸ CACNA1B Q00975 1/20 0.38
▸ TSPO P30536 1/20 0.38
▸ PPARG P37231 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29765181 0.84 L3MBTL1 (0.41) ALDH1A1HTTSMN1; SMN2L3MBTL1NR1D1
SCHEMBL21741216 0.84 L3MBTL1 (0.41) ALDH1A1HTTSMN1; SMN2L3MBTL1NR1D1
SCHEMBL25609123 0.84 NR1D1 (0.43) ALDH1A1HTTSMN1; SMN2L3MBTL1NR1D1
SCHEMBL24291657 0.82 ALDH1A1 (0.43) ALDH1A1HTTSMN1; SMN2L3MBTL1NR1D1
SCHEMBL29607533 0.80 L3MBTL1 (0.45) ALDH1A1L3MBTL1MEN1KMT2A
SCHEMBL24610200 0.79 TSHR (0.40) ALDH1A1HTTSMN1; SMN2L3MBTL1NR1D1
SCHEMBL29765192 0.79 TSHR (0.40) ALDH1A1HTTSMN1; SMN2L3MBTL1NR1D1
SCHEMBL8893537 0.79 LDHA (0.44) ALDH1A1HTTSMN1; SMN2L3MBTL1NR1D1
SCHEMBL25448644 0.78 HTT (0.49) ALDH1A1HTTSMN1; SMN2L3MBTL1NR1D1
SCHEMBL11579749 0.78 LDHA (0.43) ALDH1A1HTTSMN1; SMN2L3MBTL1NR1D1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11718610-B2 Compounds containing benzosultam MEDSHINE DISCOVERY INC. (CN) 2023-08-08 — — US disclosed
US-20230183230-A1 COMPOUNDS CONTAINING BENZOSULTAM SUZHOU GENHOUSE BIO CO., LTD. (CN) 2023-06-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230183230-A1 COMPOUNDS CONTAINING BENZOSULTAM TBXA2R, TBXAS1, SULT2A1 ALDH1A1 299/4885HTT 2092/4885SMN1; SMN2 2930/4885
US-11718610-B2 Compounds containing benzosultam TBXA2R, TBXAS1, SULT2A1 ALDH1A1 299/4885HTT 2092/4885SMN1; SMN2 2930/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback